Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4951 to 4965 of 7689 results

  1. NICE encourages further research into the use of innovative technologies for the management of severe acute respiratory failure, and may review this guidance on publication of further evidence.

    Recommendation ID IPG391/1 Question NICE encourages further research into the use of innovative technologies for the management of severe

    Research recommendation
    Published
    9 June 2015

  2. NICE encourages further research on subretinal prosthesis system for retinitis pigmentosa. Outcomes should include the impact on quality of life and activities of day-to-day living, and durability of implants. NICE may update the guidance on publication of further evidence.

    Recommendation ID IPG537/1 Question NICE encourages further research on subretinal prosthesis system for retinitis pigmentosa. Outcomes

    Research recommendation
    Published
    25 January 2016

  3. NICE encourages further research on transcranial magnetic stimulation (TMS) for treating and preventing migraine. Data should be collected for all patients not entered into controlled trials. Studies should describe clearly whether its use is for treatment or prevention. They should report details of patient selection and the dose and frequency of use. Outcome measures should include the number and severity of migraine episodes, and quality of life in both the short and long term. The development of any neurological disorders (such as epilepsy) in the short or longer term after starting treatment should be documented.

    Recommendation ID IPG477/1 Question NICE encourages further research on transcranial magnetic stimulation (TMS) for treating and preventing

    Research recommendation
    Published
    9 June 2015

  4. NICE encourages further research into the effects of uterine artery embolisation compared with other procedures to treat adenomyosis, particularly for patients wishing to maintain or improve their fertility.

    Recommendation ID IPG473/1 Question NICE encourages further research into the effects of uterine artery embolisation compared with other

    Research recommendation
    Published
    9 June 2015

  5. Evidence on the safety of magnetic resonance therapy for knee osteoarthritis shows no major safety concerns. Evidence on efficacy is inadequate in quality and quantity and shows no benefit over placebo. Therefore, this procedure should not be used unless it is part of a research study. Further research should be in the form of appropriately powered randomised  controlled trials comparing the procedure with placebo. It should report patient  selection and treatment protocols, including the number of sessions and  magnetic field strength.

    Recommendation ID IPG702/1 Question Evidence on the safety of magnetic resonance therapy for knee osteoarthritis shows no major safety

    Research recommendation
    Published
    30 September 2021

  6. Evidence on the safety of transcutaneous electrical neuromuscular stimulation for urinary incontinence raises no major safety concerns. Evidence on its efficacy is limited in quantity and quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page.

    Recommendation ID IPG735/01 Question Evidence on the safety of transcutaneous electrical neuromuscular stimulation for urinary incontinence

    Research recommendation
    Published
    7 September 2022

  7. Evidence on the safety of microwave ablation for treating primary lung cancer and metastases in the lung is adequate but shows it can cause infrequent serious complications. Evidence on its efficacy shows it reduces tumour size. But the evidence on improvement in survival, long-term outcomes and quality of life is limited in quantity and quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page. Further research should be randomised controlled trials or disease registry studies. It should report patient selection, disease progression and quality of life, and take account of the effectiveness of managing oligometastatic disease in patients.

    Recommendation ID IPG716/01 Question Evidence on the safety of microwave ablation for treating primary lung cancer and metastases in the

    Research recommendation
    Published
    24 March 2022

  8. Expectant management before IVF:- What is the optimum period of expectant management for women of different age groups before invasive treatment such as IVF is considered?

    Recommendation ID CG156/1 Question Expectant management before IVF:- What is the optimum period of expectant management for women of different

    Research recommendation
    Published
    9 June 2015

  9. Evidence on the safety of repetitive short-pulse transscleral cyclophotocoagulation for glaucoma shows no major safety concerns. Evidence on efficacy is inadequate in quality. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE website.

    Recommendation ID IPG692/1 Question Evidence on the safety of repetitive short-pulse transscleral cyclophotocoagulation for glaucoma shows

    Research recommendation
    Published
    16 August 2021

  10. Exposure to air pollution using different modes of transport How does altering a person's mode of transport and route affect their personal exposure to air pollution?

    Recommendation ID NG70/6 Question Exposure to air pollution using different modes of transport How does altering a person's mode of transport

    Research recommendation
    Published
    12 October 2018

  11. Facilitators and barriers to carrying out daily mouth care and oral health assessments for adults in care homes:- What are the facilitators and barriers to delivering daily oral care and conducting oral health assessments in residential and nursing care homes?

    Recommendation ID NG48/6 Question Facilitators and barriers to carrying out daily mouth care and oral health assessments for adults in

    Research recommendation
    Published
    24 August 2016

  12. What are the key factors, including additional care and support, that influence participation* and quality of life in people with neuropathic pain?

    Recommendation ID CG173/4 Question What are the key factors, including additional care and support, that influence participation* and quality

    Research recommendation
    Published
    26 October 2020

  13. Factors affecting participation and quality of life:- What are the key factors, including additional care and support, that influence participation and quality of life in people with neuropathic pain?

    Recommendation ID CG173/4 Question Factors affecting participation and quality of life:- What are the key factors, including additional

    Research recommendation
    Published
    9 June 2015

  14. Factors associated with sustained, high-quality residential care:- What factors (including service organisation and management, staff composition, training andsupervision, and the content of care and support) are associated with sustained high-quality residential care for people with a learning disability and behaviour that challenges?

    Recommendation ID NG11/4 Question Factors associated with sustained, high-quality residential care:- What factors (including service organisation

    Research recommendation
    Published
    5 October 2015

  15. Factors predicting outcomes for people with high-grade transformation of follicular lymphoma:- In people with high-grade transformation of follicular lymphoma, which biological and clinical factors predict good outcomes with immunochemotherapy alone?

    Recommendation ID NG52/2 Question Factors predicting outcomes for people with high-grade transformation of follicular lymphoma:- In people

    Research recommendation
    Published
    25 August 2016